Breathe Well Live Well
|
UPDATE 1-AstraZeneca builds pipeline with $232 mln Synairgen asthma deal
Reuters LONDON, June 12 (Reuters) – AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest … |
View full post on asthma – Google News
Reuters UK |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Fox Business AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest drugmaker – subject of a … AstraZeneca extends global shopping spree with $232M asthma drug deal Synairgen breathes easier with $225M from Astrazeneca for its asthma drug |
View full post on asthma – Google News
Reuters |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Reuters AstraZeneca plans to start a mid-stage Phase IIa study with the drug in early 2015 in patients with severe asthma, building on results from an initial Phase lla trial in a broad asthma population. Severe asthma is a growing focus for major drugmakers … Synairgen shares soar on AstraZeneca asthma deal AstraZeneca licenses rights to Synairgen asthma drug |
View full post on asthma – Google News
|
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Yahoo News LONDON (Reuters) – AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest … AstraZeneca Licences Asthma Exacerbation Treatment From Synairgen AstraZeneca licenses rights to Synairgen asthma drug Synairgen shares soar on AstraZeneca asthma deal |
View full post on asthma – Google News
|
Research and Markets: Global Asthma Pipeline Highlights – 2014
Business Wire (press release) The latest report Asthma Pipeline Highlights – 2014, provides most up-to-date information on key pipeline molecules in the global asthma market. It covers emerging therapies for asthma in active clinical development stages including early and late … |
View full post on asthma – Google News
|
Research and Markets: Global Asthma Pipeline Highlights – 2014
The Herald | HeraldOnline.com (press release) The latest report Asthma Pipeline Highlights – 2014, provides most up-to-date information on key pipeline molecules in the global asthma market. It covers emerging therapies for asthma in active clinical development stages including early and late … |
View full post on asthma – Google News
|
Research and Markets: Global Asthma Pipeline Highlights – 2014
4-traders (press release) The latest report Asthma Pipeline Highlights – 2014, provides most up-to-date information on key pipeline molecules in the global asthma market. It covers emerging therapies for asthma in active clinical development stages including early and late … |
View full post on asthma – Google News
|
Asthma – Pipeline Review, H2 2013: New Research Report Available at Fast …
SBWire (press release) Boston, MA — (SBWIRE) — 09/27/2013 — Global Markets Direct's, 'Asthma – Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Asthma, complete … |
View full post on asthma – Google News
|
Research and Markets: Asthma – Pipeline Review, H2 2013 Reviews Key …
Fort Mills Times Global Markets Direct's, 'Asthma – Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Asthma, complete with latest updates, and special features … |
View full post on asthma – Google News
|
Research and Markets: Asthma – Pipeline Review, H1 2013
Fort Mills Times Asthma – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university … |
View full post on asthma – Google News